Showing items 831-855 of 4992 (200 Page(s) Totally)
<< < 29 30 31 32 33 34 35 36 37 38 > >>
View [10|25|50] records per page
| 國立成功大學 |
2024-06 |
The potential value of a quantitative PCR assay for assessing respiratory samples in approaching a laboratory diagnosis of pulmonary mucormycosis
|
Chen;Ya-Ping;Cia;Cong-Tat;Hsu;Ya-Ting;Chen;-Lin, Po;Chen;Tsai-Yun;Lee;Jen-Chieh;Li;Sin-Syue;Hsieh;Ming-;I;Wang;Hsuan-Chen;Wu;Chi-Jung |
| 國立成功大學 |
2024-06 |
A risk stratification model modified from the U.S. guideline could be applied in an Asian population with or without ASCVD: Validation study
|
Hsiao;Yu-Chung;Lee;Thung-Lip;Lin;Fang-Ju;Hsuan;Chin-Feng;Yeh;Chih-Fan;Chang;Wei-Tien;Kao;Hsien-Li;Jeng;Jiann-Shing;Wu;Yen-Wen;Hsieh;I-Chang;Fang;Ching-Chang;Wang;Kuo-Yang;Chang;Kuan-Cheng;Lin;Tsung-Hsien;Sheu;Wayne, Huey-Herng;Li;Yi-Heng;Yin;Wei-Hsian;Yeh;Hung-;I;Chen;Jaw-Wen;Wu;Chau-Chung |
| 國立成功大學 |
2024-06 |
Utilizing Artificial Neural Networks for Establishing Hearing-Loss Predicting Models Based on a Longitudinal Dataset and Their Implications for Managing the Hearing Conservation Program
|
Khajonklin;Thanawat;Sun;Yih-Min;Guo;Leon, Yue-Liang;Hsu;Hsin-;I;Yoon;Sik, Chung;Lin;Cheng-Yu;Tsai;Perng-Jy |
| 國立成功大學 |
2024-06 |
Extending finite mixtures of nonlinear mixed-effects models with covariate-dependent mixing weights
|
Wang;Wan-Lun;Yang;Yu-Chen;Lin;Tsung-;I |
| 國立成功大學 |
2024-06 |
Performance Improvement of a-In-Ga-Sn-O Thin-Film Transistor with Oxygen Doping by Reactive Sputtering Method
|
Liao;Tsung-;I;Chang;Sheng-Po;Shi;Wen-Xiang;Chang;Shoou-Jinn;Chen;Jone-Fang |
| 國立成功大學 |
2024-06 |
Estimation of natural convection heat transfer characteristics of rack server in a cavity: experimental and numerical analyzes
|
Chen;Han-Taw;Chen;Kuan-Xun;Amani;Mohammad;Rysavy;J;Yan;Wei-Mon |
| 國立成功大學 |
2024-06 |
Evidence of the γ-ray counterpart of nova FM Cir from Fermi-LAT
|
Wang;H, H. H.;Yan;H, D.;Lin;L, C. -C.;Takata;J;Tam;P, -H. T. |
| 國立成功大學 |
2024-06 |
Vibostolimab coformulated with pembrolizumab (vibo/ pembro) plus chemotherapy (chemo) as first-line treatment for advanced esophageal cancer (ec): Results from cohort E of the phase II KEYVIBE-005 study
|
Hsu;C-H;Dziadziuszko;R;Abreo, Gomez;D, A.;Aksoy;S;Martin, Gil;M;Roderburg;C;Yen;C, J.;Arican;A;Cassier;P;Im;S-A;Kim;S-B;Kudo;T;Ochsenreither;S;Sendur;M, A. N.;Yonemori;K;Rojas;C, I.;Liu;Q;Keenan;T;Healy;J;Kwiatkowski;M |
| 國立成功大學 |
2024-06 |
Vibostolimab coformulated with pembrolizumab (vibo/ pembro) plus chemotherapy (chemo) as first-line treatment for advanced esophageal cancer (ec): Results from cohort E of the phase II KEYVIBE-005 study
|
Hsu;C-H;Dziadziuszko;R;Abreo, Gomez;D, A.;Aksoy;S;Martin, Gil;M;Roderburg;C;Yen;C, J.;Arican;A;Cassier;P;Im;S-A;Kim;S-B;Kudo;T;Ochsenreither;S;Sendur;M, A. N.;Yonemori;K;Rojas;C, I.;Liu;Q;Keenan;T;Healy;J;Kwiatkowski;M |
| 國立成功大學 |
2024-06 |
Recovery of Lithium from Industrial Li-Containing Wastewater Using Fluidized-Bed Homogeneous Granulation Technology
|
Le;Giang, Van;Luu;Anh, The;Tran;Tuan, Huu;Bui;Ngoc, T.;Mofijur;M;Nguyen;Ky, Minh;Bui;Thanh, Xuan;Bahari;M, B.;Vo;Phong, Hoang Nhat;Vu;Thanh, Chi;Chien;Chang, Guo-Ping;Huang;Yao-Hui |
| 國立成功大學 |
2024-06 |
Vibostolimab coformulated with pembrolizumab (vibo/ pembro) plus chemotherapy (chemo) as first-line treatment for advanced esophageal cancer (ec): Results from cohort E of the phase II KEYVIBE-005 study
|
Hsu;C-H;Dziadziuszko;R;Abreo, Gomez;D, A.;Aksoy;S;Martin, Gil;M;Roderburg;C;Yen;C, J.;Arican;A;Cassier;P;Im;S-A;Kim;S-B;Kudo;T;Ochsenreither;S;Sendur;M, A. N.;Yonemori;K;Rojas;C, I.;Liu;Q;Keenan;T;Healy;J;Kwiatkowski;M |
| 國立成功大學 |
2024-06 |
An inverse method of fundamental solutions for the identification of 2D elastic properties of anisotropic solids
|
Hematiyan;M, R.;Khosravifard;A;Mohammadi;M;Shiah;Y, C. |
| 國立成功大學 |
2024-06 |
Investigating the protective role of CD44 and microRNA-146a in tendinopathic tenocytes: a signaling axis regulating apoptosis
|
Chen;S;Wu;P |
| 國立成功大學 |
2024-06 |
Vibostolimab coformulated with pembrolizumab (vibo/ pembro) plus chemotherapy (chemo) as first-line treatment for advanced esophageal cancer (ec): Results from cohort E of the phase II KEYVIBE-005 study
|
Hsu;C-H;Dziadziuszko;R;Abreo, Gomez;D, A.;Aksoy;S;Martin, Gil;M;Roderburg;C;Yen;C, J.;Arican;A;Cassier;P;Im;S-A;Kim;S-B;Kudo;T;Ochsenreither;S;Sendur;M, A. N.;Yonemori;K;Rojas;C, I.;Liu;Q;Keenan;T;Healy;J;Kwiatkowski;M |
| 國立成功大學 |
2024-06 |
Vibostolimab coformulated with pembrolizumab (vibo/ pembro) plus chemotherapy (chemo) as first-line treatment for advanced esophageal cancer (ec): Results from cohort E of the phase II KEYVIBE-005 study
|
Hsu;C-H;Dziadziuszko;R;Abreo, Gomez;D, A.;Aksoy;S;Martin, Gil;M;Roderburg;C;Yen;C, J.;Arican;A;Cassier;P;Im;S-A;Kim;S-B;Kudo;T;Ochsenreither;S;Sendur;M, A. N.;Yonemori;K;Rojas;C, I.;Liu;Q;Keenan;T;Healy;J;Kwiatkowski;M |
| 國立成功大學 |
2024-06 |
Vibostolimab coformulated with pembrolizumab (vibo/ pembro) plus chemotherapy (chemo) as first-line treatment for advanced esophageal cancer (ec): Results from cohort E of the phase II KEYVIBE-005 study
|
Hsu;C-H;Dziadziuszko;R;Abreo, Gomez;D, A.;Aksoy;S;Martin, Gil;M;Roderburg;C;Yen;C, J.;Arican;A;Cassier;P;Im;S-A;Kim;S-B;Kudo;T;Ochsenreither;S;Sendur;M, A. N.;Yonemori;K;Rojas;C, I.;Liu;Q;Keenan;T;Healy;J;Kwiatkowski;M |
| 國立成功大學 |
2024-06 |
Investigating the protective role of CD44 and microRNA-146a in tendinopathic tenocytes: a signaling axis regulating apoptosis
|
Chen;S;Wu;P |
| 國立成功大學 |
2024-06 |
The hepatic fibrogenic effect of aberrant IgG-Fc glycosylation
|
Ho;C;Chang;T;Wang;S |
| 國立成功大學 |
2024-06 |
Exosomal EPHA2 and EHD1 proteins promote lung cancer metastasis
|
Chen;Y;Weng;S;Hong;T |
| 國立成功大學 |
2024-06 |
The oncogenic role and clinical significance of RNA N6-methyladenosine regulator METTL3 and IGF2BP3 in hepatocellular carcinoma
|
Wang;W;Huang;Y;Wang;S;Yen;C |
| 國立成功大學 |
2024-06 |
Vibostolimab coformulated with pembrolizumab (vibo/ pembro) plus chemotherapy (chemo) as first-line treatment for advanced esophageal cancer (ec): Results from cohort E of the phase II KEYVIBE-005 study
|
Hsu;C-H;Dziadziuszko;R;Abreo, Gomez;D, A.;Aksoy;S;Martin, Gil;M;Roderburg;C;Yen;C, J.;Arican;A;Cassier;P;Im;S-A;Kim;S-B;Kudo;T;Ochsenreither;S;Sendur;M, A. N.;Yonemori;K;Rojas;C, I.;Liu;Q;Keenan;T;Healy;J;Kwiatkowski;M |
| 國立成功大學 |
2024-06 |
The hepatic fibrogenic effect of aberrant IgG-Fc glycosylation
|
Ho;C;Chang;T;Wang;S |
| 國立成功大學 |
2024-06 |
Exosomal EPHA2 and EHD1 proteins promote lung cancer metastasis
|
Chen;Y;Weng;S;Hong;T |
| 國立成功大學 |
2024-06 |
Unraveling conformational changes and alternative catalytic pathways in the crystal structures of Lactobacillus plantarum tannase
|
Jeng;W;Liu;C;Ko;T;Lee;C;Lin;H;Wang;A, H. |
| 國立成功大學 |
2024-06 |
Vibostolimab coformulated with pembrolizumab (vibo/ pembro) plus chemotherapy (chemo) as first-line treatment for advanced esophageal cancer (ec): Results from cohort E of the phase II KEYVIBE-005 study
|
Hsu;C-H;Dziadziuszko;R;Abreo, Gomez;D, A.;Aksoy;S;Martin, Gil;M;Roderburg;C;Yen;C, J.;Arican;A;Cassier;P;Im;S-A;Kim;S-B;Kudo;T;Ochsenreither;S;Sendur;M, A. N.;Yonemori;K;Rojas;C, I.;Liu;Q;Keenan;T;Healy;J;Kwiatkowski;M |
Showing items 831-855 of 4992 (200 Page(s) Totally)
<< < 29 30 31 32 33 34 35 36 37 38 > >>
View [10|25|50] records per page
